Deutsche Bank’s Zentalis Pharmaceuticals ZNTL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-42,804
| Closed | -$68.1K | – | 3724 |
|
|
2025
Q1 | $68.1K | Hold |
42,804
| – | – | ﹤0.01% | 3283 |
|
|
2024
Q4 | $130K | Buy |
42,804
+10,873
| +34% | +$32.9K | ﹤0.01% | 3184 |
|
|
2024
Q3 | $118K | Buy |
31,931
+8,184
| +34% | +$30.1K | ﹤0.01% | 3115 |
|
|
2024
Q2 | $97.1K | Sell |
23,747
-7,078
| -23% | -$28.9K | ﹤0.01% | 3082 |
|
|
2024
Q1 | $486K | Sell |
30,825
-12,081
| -28% | -$190K | ﹤0.01% | 2328 |
|
|
2023
Q4 | $650K | Buy |
42,906
+10,826
| +34% | +$164K | ﹤0.01% | 2204 |
|
|
2023
Q3 | $644K | Sell |
32,080
-387,146
| -92% | -$7.77M | ﹤0.01% | 1980 |
|
|
2023
Q2 | $11.8M | Buy |
419,226
+374,402
| +835% | +$10.6M | 0.01% | 927 |
|
|
2023
Q1 | $771K | Buy |
44,824
+7,428
| +20% | +$128K | ﹤0.01% | 2252 |
|
|
2022
Q4 | $753K | Sell |
37,396
-31,258
| -46% | -$630K | ﹤0.01% | 2223 |
|
|
2022
Q3 | $1.49M | Buy |
68,654
+46,126
| +205% | +$999K | ﹤0.01% | 1747 |
|
|
2022
Q2 | $633K | Sell |
22,528
-10,624
| -32% | -$299K | ﹤0.01% | 2445 |
|
|
2022
Q1 | $1.53M | Sell |
33,152
-1,834
| -5% | -$84.6K | ﹤0.01% | 2046 |
|
|
2021
Q4 | $2.94M | Buy |
34,986
+1,183
| +3% | +$99.5K | ﹤0.01% | 1750 |
|
|
2021
Q3 | $2.25M | Buy |
33,803
+11,438
| +51% | +$762K | ﹤0.01% | 2001 |
|
|
2021
Q2 | $1.19M | Buy |
22,365
+831
| +4% | +$44.2K | ﹤0.01% | 2656 |
|
|
2021
Q1 | $934K | Sell |
21,534
-1,843
| -8% | -$79.9K | ﹤0.01% | 2698 |
|
|
2020
Q4 | $1.21M | Buy |
23,377
+17,122
| +274% | +$889K | ﹤0.01% | 2307 |
|
|
2020
Q3 | $205K | Buy |
6,255
+1,019
| +19% | +$33.4K | ﹤0.01% | 3167 |
|
|
2020
Q2 | $252K | Buy |
+5,236
| New | +$252K | ﹤0.01% | 2990 |
|